1 Rezaie A, Pimentel M, Rao SS. How to test and treat small intestinal bacterial overgrowth: an evidence-based approach. Curr Gastroenterol Rep. 2016;18(2);8.
2 Dukowicz AC, Lacy BE, Levine GM. Small Intestinal Bacterial Overgrowth: A Comprehensive Review. Gastroenterology & Hepatology. 2007;3(2):112–22.
3 Grace E, Shaw C, Whelan K, Andreyev HJ. Review article: small intestinal bacterial overgrowth – prevalence, clinical features, current and developing diagnostic tests and treatment. Aliment Phramacol Ther. 2013;38:674–88.
4 Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrom: a double-blinde, randomized, placebo-controlled study. Am J Gastroenterol. 2003;98:412–9.
4 Rubio-Tapia A, Barton SH, Rosenblatt JE, Murray JA. Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease. J Clin Gastroenterol. 2009;43:157–61.
5 Walker MM, Talley NJ. Review article: bacteria and pathogenesis of disease in the upper gastrointestinal tract--beyond the era of Helicobacter pylori. Aliment Pharmacol Ther. 2014;39:767.
6 Khoshini R, Dai SC, Lezcano S, Pimentel M. A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci. 2008;53:1443.
7 Quigley EM. Small intestinal bacterial overgrowth: what it is and what it is not. Curr Opin Gastroenterol. 2014 Mar;30(2):141–6.
8 Phillips SF, Quigley EM, Kumar D, Kamath PS. Motility of the ileocolonic junction. Gut. 1988;29:390.
9 Roland BC, Ciarleglio MM, Clarke JO, et al. Low ileocecal valve pressure is significantly associated with small intestinal bacterial overgrowth (SIBO). Dig Dis Sci. 2014;59:1269.
10 Vantrappen G, Janssens J, Hellemans J, Ghoos Y. The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest. 1977;59:1158.
11 Bures J, Cyrany J, Kohoutova D, et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol. 2010;16:2978.
12 Jones RM, Neish AS. Recognition of bacterial pathogens and mucosal immunity. Cell Microbiol. 2011;13:670.
13 Posserud I, Stotzer PO, Björnsson ES, Abrahamsson H,Simrén M. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut. 2007;56:802–8.
14 Jones RM, Neish AS. Recognition of bacterial pathogens and mucosal immunity. Cell Microbiol. 2011;13:670.
15 Kirsch M. Bacterial overgrowth. Am J Gastroenterol. 1990;85:231.
16 Shindo K, Machida M, Koide K, et al. Deconjugation ability of bacteria isolated from the jejunal fluid of patients with progressive systemic sclerosis and its gastric pH. Hepatogastroenterology. 1998;45:1643.
17 Donaldson RM Jr. Role of enteric microorganisms in malabsorption. Fed Proc. 1967;26:1426.
18 Pai RK. A practical approach to small bowel biopsy interpretation: celiac disease and its mimics. Semin Diagn Pathol 2014; 31:124.
19 Sherman P, Lichtman S. Small bowel bacterial overgrowth syndrome. Dig Dis 1987; 5:157.
20 Su J, Smith MB, Rerknimitr R, Morrow D. Small intestine bacterial overgrowth presenting as protein-losing enteropathy. Dig Dis Sci. 1998;43:679.
21 Justus PG, Fernandez A, Martin JL, et al. Altered myoelectric activity in the experimental blind loop syndrome. J Clin Invest. 1983;72:1064.
22 Gibson GR, Cummings JH, Macfarlane GT, et al. Alternative pathways for hydrogen disposal during fermentation in the human colon. Gut. 1990;31(6):679–83.
23 Furnari M, Savarino E, Bruzzone L, et al. Reassessment of the role of methane production between irritable bowel syndrome and functional constipation.J Gastrointest Liver Dis. 2012;21:157–63.
24 Gasbarrini A, Lauritano E, Gabrielli M, Scarpellini E, Lupascu A, Ojetti V, et al. Small intestinal bacterial overgrowth: diagnosis and treatment. Dig Dis. 2007;25:237–40.
25 Corazza GR, et al. The diagnosis of small bowel bacterial overgrowth: reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology. 1990;98(2):302–9.
26 Perman JA, et al. Fasting breath hydrogen concentration: normal values and clinical application. Gastroenterology. 1984;87(6):1358–63.
27 Vanderhoof JA, Young RJ, Murray N, Kaufman SS. Treatment strategies for small bowel bacterial overgrowth in short bowel syndrome. J Pediatr Gastroenterol Nutr. 1998;27:155.
28 Malik BA, Xie YY, Wine E, Huynh HQ. Diagnosis and pharmacological management of small intestinal bacterial overgrowth in children with intestinal failure. Can J Gastroenterol. 2011;25:41.
28 Yu D, Cheeseman F, Vanner S. Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS. Gut. 2011;60(3):334–40.
29 Parodi A, Sessarego M, Greco A, et al. Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication. Am J Gastroenterol. 2008;103:1257.
30 Fried M, Siegrist H, Frei R, et al. Duodenal bacterial overgrowth during treatment in outpatients with omeprazole. Gut. 1994;35:23.
31 Ansuini V, Giorgio V, Filoni S, Barbaro F, Gasbarrini A, Rossi C. Fecal calprotectin concentration in children affected by SIBO. Eur Rev Med Pharmacol Sci. 2011 Nov;15(11):1328–35.
32 Montalto M, Santoro L, Dalvai S, Curigliano V, D’Onofrio F, Scarpellini E, et al. Fecal calprotectin concentrations in patients with small intestinal bacterial overgrowth. Dig Dis. 2008;26(2):183–6.
33 Marie I, Leroi AM, Menard JF, Levesque H, Quillard M, Ducrotte P. Fecal calprotectin in systemic sclerosis and review of the literature. Autoimmun Rev. 2015 Jun;14(6):547–54.
34 Taylor SF, Sondheimer JM, Sokol RJ, et al. Noninfectious colitis associated with short gut syndrome in infants. J Pediatr. 1991;119:24.
35 Klaus J, Spaniol U, Adler G, et al. Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn’s Disease. BMC Gastroenterol. 2009;9:61.
36 Soudah HC, Hasler WL, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med. 1991;325:1461.
37 Singh VV, Toskes PP. Small Bowel Bacterial Overgrowth: Presentation, Diagnosis, and Treatment. Curr Treat Options Gastroenterol. 2004;7:19.
38 Quigley EM, Abu-Shanab A. Small intestinal bacterial overgrowth. Infect Dis Clin North Am. 2010;24:943.
39 Shah SC, Day LW, Somsouk M, Sewell JL. Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2013;38:925.
40 Scarpellini E, Gabrielli M, Lauritano CE, et al. High dosage rifaximin for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2007;25:781.
41 Yang J, Lee HR, Low K, et al. Rifaximin versus other antibiotics in the primary treatment and retreatment of bacterial overgrowth in IBS. Dig Dis Sci. 2008;53:169.
42 Pimentel M, Morales W, Chua K, et al. Effects of rifaximin treatment and retreatment in nonconstipated IBS subjects. Dig Dis Sci. 2011;56:2067.
43 Chedid V, Dhalla S, Clarke JO, et al. Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth. Glob Adv Health Med. 2014 May;3(3):16–24.
44 Gaon D, Garmendia C, Murrielo NO, et al. Effect of Lactobacillus strains (L. casei and L. Acidophillus Strains cerela) on bacterial overgrowth-related chronic diarrhea. Medicina (B Aires). 2002;62:159.
45 Scientific concepts of functional foods in Europe. Consensus document. Br J Nutr. 1999;81 Suppl 1:1.
46 Hegar B, Hutapea EI, Advani N, Vandenplas Y. A double-blind placebo-controlled randomized trial on probiotics in small bowel bacterial overgrowth in children treated with omeprazole. J Pediatr (Rio J). 2013;89:381.
47 Pimentel M, Constantino T, Kong Y, et al. A 14-day elemental diet is highly effective in normalizing the lactulose breath test. Dig Dis Sci. 2004;49:73–7.
48 Gibson PR, Barrett JS, Muir JG. Functional bowel symptoms and diet. Internal Med Jour. 2013;1067–74.
49 Ferrier DA. Lippincott’s Illistrated Reviews : Biochemistry. 6th Edition. Lippincott Williams and Wilkins (Philadelphia) 2014.
50 Jeppesen P, Mortensen P. The influence oa a preserved colon on the absorption of medium chain fat in patients with small bowel resection. Gut. 1998;43:478–83.
51 Asp N-GL. Classification and methodology of food carbohydrates as related to nutritional effects. A J Clin Nutr. 1995;930–7.
52 Barrett JS, Gibson PR. Clinical ramifications of malabsorption of fructose and other short-chain carbohydrates. Practical Gastroenterology. 2007;51–65.
53 Dhingra, Devinder, et al. Dietary fibre in foods: a review. J Food Sci Technol. 2012;255–66.
54 Zhao J, et al. Lactose intolerance in patients with chronic functional diarrhoea: the role of small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2010;892–900.
55 Haas SV, Haas MP. (2011) The Management of Celiac Disease. Literary Licensing. ISBN 1-258-19621-2.
56 Suskind DL, et al. Patients Perceive Clinical Benefit with the Specific Carbohydrate Diet for Inflammatory Bowel Disease. Dig Dis Sci. 2016;3255–60.
57 Knight-Sepulveda K, Kais S, Santaolalla R, Abreu MT. Diet and Inflammatory Bowel Disease. Gastroenterol Hepatol. 2015;11(8):511–20.
58 Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. J Gastroenterol Hepatol. 2010;252–8.
59 Wilhelmi M, Dolder M, Tutuian R. FODMAP – eine häufige Ursache unklarer abdomineller Beschwerden. Schweiz Med Forum. 2014;14(48):909–14 .
60 Bundesamt für Gesundheit BAG: Kohlenhydrate in der Ernährung. Stellungnahme und Empfehlungen der Eidgenössischen Ernährungskommission (EEK) 2009.
61 Halmos, Emma P, et al. Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut. 2015;64(1):93–100.
62 Small Intestine Bacterial Overgrowth: Often-Ignored Cause of Irritable Bowel Syndrome. Siebecker A, Sandberg-Lewis S. Townsend Letter, Feb/March 2013
63 Rezaie A, Buresi M, Lembo A, Lin H, McCallum R, Rao S, et al. Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus. Am J Gastroenterol. 2017;112(5):775–784..